欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (4): 470-473.

• 研究原著 • 上一篇    下一篇

热毒宁注射液治疗急性上呼吸道感染的临床研究

黄小民, 柳于介1, 何煜舟, 陈方帆, 汪云开   

  1. 浙江中医学院附属医院急诊科, 杭州310006, 浙江;
    1江苏康缘药业股份有限公司, 连云港222001, 江苏
  • 收稿日期:2005-12-20 修回日期:2006-03-11 出版日期:2006-04-26 发布日期:2020-12-08
  • 通讯作者: 黄小民, 男, 主任医师, 教授, 硕士生导师, 研究方向:急诊医学。Tel:0571-87072119  E-mial:MXH251770@Yahoo.com

Clinical observation of Reduning injection in treatment of patients with acute upper respiratory tract infections

HUANG Xiao-min, LIU Yu-jie1, HE Yu-zhou, CHEN Fang-fan, WANG Yun-kai   

  1. Department of Emergency, the Affiliated Hospital of Zhejiang Chinese Traditional Medicine College, Hangzhou 310006, Zhejiang, China;
    1Jiangsu Kanion Pharmaceutical Co.Ltd., Lianyungang 222001, Jiangsu, China
  • Received:2005-12-20 Revised:2006-03-11 Online:2006-04-26 Published:2020-12-08

摘要: 目的:评价热毒宁注射液治疗急性上呼吸道感染外感风热证的疗效和安全性。方法:71 例急性上呼吸道感染病人随机分为2 组, 试验组给予热毒宁注射液治疗, 20 ml·次·dB2, 静脉滴注;对照组给予清开灵注射液治疗, 1 次·dB2, 每次30 ml, 静脉滴注。3 d 为一个疗程。结果:治疗d 3 试验组总体疗效优于对照组(98.08 %, 94.13 %, P <0.01)。治疗d 3 试验组中医证候疗效优于对照组(98.07 %,94.11 %, P <0.05)。未见明显的毒副作用和不良反应症状。结论:用药3 d 后热毒宁注射液治疗急性上呼吸道感染外感风热证的疗效优于清开灵注射液, 并且安全性良好。

关键词: 呼吸道感染, 外感风热证, 呼吸系统药, 安全, 随机对照试验, 药物评价, 热毒宁注射液

Abstract: AIM: To evaluate the efficacy and safety of Reduning injection in treating acute upper respiratory tract infections.METHODS: Seventy-one patients were randomly assigned to two groups.Fifty-three patients in trial group were administrated with Redunimg injection 20 ml, iv gtt, qd, while the other in control group were administrated with Qingkailing injection 30ml, iv gtt, qd. The period of treatment was 3 d for each group.RESULTS: On d 3 after treatment, the total clinical effective rate were 98 % in the trial group and 94 % in the control group with significant difference between two groups (P <0.01), while the total effective rate of Chinese traditional medical symptoms were 98 % in the trial group and 94 % in the control group with significant difference between two groups (P <0.05).In trial and control groups no adverse reactions was found.CONCLUSION: Reduning injection is an effective and safe agent in treatment of patients with acute upper respiratory tract infections.

Key words: respiratory tract infections, respiratory system agents, safety, randomized controlled trials, drug evaluation, Reduning injection

中图分类号: